fincash logo SOLUTIONS

Fincash » Search » ERIS Lifesciences Ltd

ERIS Lifesciences Ltd

Updated on September 21, 2020

Stock/Share Code - ERIS

Eris Lifesciences Limited is an India-based company, which is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market.

Below is the details of ERIS ERIS Lifesciences Ltd

Market Cap₹6,539 Cr.
Current Price ₹539.8 as on 25 Sep 20
52 Week High / Low Price₹595 / ₹321
Face Value₹1
Stock P/E22.06
Book Value₹95.68
Dividend Yield1.14 %
ROCE24.64 %
ROE23.73 %
Sales Growth (3yrs)12.69 %
IndustryPharmaceuticals - Indian - Formulations
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free. Company has a good return on equity (ROE) track record: 3 Years ROE 29.26%
Cons: Tax rate seems low Debtor days have increased from 36.98 to 50.99 days.

ERIS Lifesciences Ltd Price Chart

ERIS Lifesciences Ltd Price Chart

ERIS Lifesciences Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Ajanta Pharma ₹1,550.55 25.72 ₹12,954.81 Cr. 0.88 ₹147.76 Cr. 28.90 9.19 668.20 27.61
2. ERIS Lifescience 22.06 ₹6,539.2 Cr. 1.14 ₹87.13 Cr. 6.31 -0.32 261.48 24.64
3. Caplin Point Lab ₹552.25 17.61 ₹3,861.18 Cr. 0.41 ₹54.53 Cr. 8.56 24.68 240.08 34.76
4. Bliss GVS Pharma ₹149.35 17.49 ₹1,479.12 Cr. 0.35 ₹16.19 Cr. -52.09 -38.76 129.55 18.56
5. Amrutanjan Healt ₹424.1 40.67 ₹1,309.97 Cr. 0.47 ₹6.43 Cr. 1018.57 4.53 46.62 22.60
6. Hester Bios ₹1,743.45 45.51 ₹1,206.1 Cr. 0.47 ₹5.72 Cr. -31.82 -10.97 39.85 16.33
7. Medicamen Biotec ₹207.1 43.51 ₹482.07 Cr. 0.25 ₹2.1 Cr. -35.98 -16.09 26.12 14.88
8. Lincoln Pharma. ₹253.35 8.15 ₹440 Cr. 0.68 ₹15.26 Cr. 20.44 7.21 103.79 22.31

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

ERIS Lifesciences Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -222182194226241231198262273254231261
YOY Sales Growth %14.78%8.54%16.13%39.58%8.44%26.67%2.24%15.82%13.33%10.17%16.28%-0.32%
Expenses -127103122142144140137162166179157161
Material Cost %14.86%14.46%14.75%14.57%14.64%14.62%15.29%17.26%16.54%16.14%14.26%16.88%
Employee Cost %13.54%19.33%18.39%19.20%16.85%18.05%20.68%17.07%17.13%19.35%22.11%20.04%
Operating Profit957972849791621001077573100
OPM %43%43%37%37%40%39%31%38%39%29%32%38%
Other Income768561012358-11
Profit before tax9877657590875992101715992
Tax %6%4%11%7%7%10%11%11%10%12%7%5%
Net Profit927458708479528292635587
EPS in Rs6.715.384.

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -2864175205486057137618971,0201,019
Sales Growth %45.90%24.80%5.29%10.49%17.74%6.69%17.87%13.80%
Expenses -224325432434435442445563665664
Material Cost %21.72%23.55%24.57%19.84%19.05%14.97%14.26%14.76%16.11%
Manufacturing Cost %0.37%0.58%0.30%2.44%1.27%5.12%1.95%0.91%0.00%
Employee Cost %14.57%15.66%16.88%22.58%20.21%16.32%17.20%18.60%18.79%
Other Cost %41.85%38.13%41.27%34.36%31.31%25.55%25.06%28.49%30.24%
Operating Profit619288114170271316334356355
OPM %22%22%17%21%28%38%42%37%35%35%
Other Income314332528321513
Profit before tax629089103154274312312324324
Tax %30%27%27%19%10%9%6%8%10%
Net Profit43666583138248294285291296
EPS in Rs3,137.104,767.834,721.166,038.048,772.1718.0521.3620.7521.2321.68
Dividend Payout %0%0%0%0%61%0%0%0%13%

Compounded Sales Growth

  • 5 Years:: 13.24%
  • 3 Years:: 12.69%
  • TTM:: 9.33%

Compounded Profit Growth

  • 5 Years:: 29.26%
  • 3 Years:: 5.86%
  • TTM:: -0.27%

Return on Equity

  • 3 Years:: -6.07%
  • 1 Year:: 26.94%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -0000014141414
Equity Capital0.
Other Liabilities -415583869682126138174
Trade Payables161933362825797592
Advance from Customers00010011
Other liability items263550496857466282
Total Liabilities961742683544026571,3701,4701,484
Fixed Assets -111564616592490484608
Gross Block15217386108113533552
Accumulated Depreciation46102443214368
Other Assets -66101106110131184335403556
Trade receivables1417222425416076143
Cash Equivalents9465929665
Loans n Advances10151410158621728310
Other asset items9141818328-10-37273
Total Assets961742683544026571,3701,4701,484

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -29409092133210236216
Profit from operations639688114172273320336
Loans Advances-3-10-07-4000
Other WC items00000-7-36-24
Working capital changes-16-24271-8-11-16-50
Direct taxes-17-31-26-23-32-52-68-70
Cash from Investing Activity --22-41-85-94-45-199-5932
Fixed assets purchased-6-7-52-13-23-49-24-37
Fixed assets sold00000001
Investments purchased-11-39-35-81-22-110-107-77
Investments sold00000000
Interest received10000132
Dividends received01000010
Invest in subsidiaries00000-77-506-11
Loans to subsidiaries00000-15-240
Shares acq cancelled00000008
Other investing items-642-0-05166117
Cash from Financing Activity --7-1-01-84-18363-221
Proceeds from shares00000001
Proceeds from borrowings00010000
Repayment of borrowings-1-1-00-0000
Interest paid fin-0-0-0-0-0-0-10-22
Dividends paid-6000-83-1700
Other financing items00000-0373-200
Net Cash Flow1-15-14-67-2

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %105%56%44%53%62%35%26%25%
Debtor Days181516161521293151
Inventory Turnover2.592.632.

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in ERIS Lifesciences Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.